Rafael Holdings, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Updates on Planned Merger with Cyclo Therapeutics
Rafael Holdings reports Q1 fiscal 2025 results, anticipates merger with Cyclo Therapeutics, and focuses on Trappsol® Cyclo™ development.Quiver AI SummaryRafael Holdings, Inc. reported its financial...